Pharmacy chains activity analysis

Pharmacy chains activity analysis

Russian pharmaceuticals retail chain segment evaluation, both on the level of the state and in particular regions. Pharmacy chains development forecast

Forecasting

Product sales and separate market development forecast, based on unique mathematical models

Business and marketing plan development

Development of detailed business-plans, required to evaluate the reasonability of project start

Search of partners for contract production in Russia

Potential partners search and evaluation, based on their technical opportunities, appropriate experience, and reputation

Monitoring of import substitution

assessment of the main trends of import substitution policies and localization processes in the pharmaceutical market in Russia, the key beneficiaries and companies at risk

Database Update: Pharmaceutical Drug Import to Russia (December 2016)

Thursday, January 19, 2017

In 2016, Russia imported 493.1 bln RUB worth of ready-made pharmaceuticals (free circulation prices). The in-bulk imports amounted to 100.2 bln RUB. In monetary terms, the imports of ready-made products and in-bulk products have increased by 8.1% and 17.1%, respectively. In physical terms, the import of ready-made products has increased by 0.5%, while the in-bulk import has a bigger rise.

Despite the obvious seasonal spike, the dynamics were mediocre, with 8.6% for ready-made drugs and 15.3% for in-bulk products. However, the imports hit an all-time high – Russia imported 59.3 bln RUB worth of pharmaceuticals in December 2016.

In physical terms, the imports have amounted to 42.8 bln minimum dosage units (MDU) since 2017, with an 8% annual dynamics, which shows a growing demand for imported pharmaceuticals.

Over the year, the number of payments in rubles for both ready-made and in-bulk imports increased more significantly, unlike payments in other currencies. In 2016, 94.4% of the import was payed for in rubles, which is 2.1% higher than in 2015. At the same time, payments in euros have fallen by nearly the same number. Russia also started to pay in Asian currencies more, in particular in Japanese yenas and Chinese yuans.

Dynamics of import of pharmaceuticals, including homeopathic and seawater drugs, to Russia, free circulation prices including customs clearance, RUB (January 2015 – December 2016)

Share: